Efficacy of radiotherapy for bone metastasis in breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors
In this study, we present the largest cohort published to date of breast cancer patients who received CDK4/6i alongside bone-directed RT. Although the observed differences in survival were not statistically significant, RT remains a viable treatment modality in metastatic breast cancer in some patients.
Authors
- Michał Jarząb (ORCID: https://orcid.org/0000-0002-2642-9724)
- Dorota Gabryś (ORCID: https://orcid.org/0000-0001-9096-2788)
- Justyna Rembak-Szynkiewicz (ORCID: https://orcid.org/0000-0002-5297-331X)
- Marcin Kubeczko (ORCID: https://orcid.org/0000-0003-1877-5691)
- Donata Gräupner (ORCID: https://orcid.org/0009-0009-8275-0422)
- Anna Polakiewicz-Gilowska (ORCID: https://orcid.org/0000-0002-2175-7067)
Institutions
- National Institute of Oncology (HU)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.radonc.2024.110639
- Citations
- 1
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.42